Kontrollieren Sie die Ausbreitung von VRE bevor es Sie kontrolliert - Thermo Fisher Scientific
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Kontrollieren Sie die Ausbreitung von VRE bevor es Sie kontrolliert
Brilliance VRE ™
Detektion von Vancomycinresistente-Enterokokken (VRE)
Brilliance™ VRE Agar ist eine chromogene Screeningplatte
zum Nachweis von Vancomycinresistente-Enterokokken
(VRE). Das Medium bietet eine präsumtive Identifizierung
von Enterococcus faecium und Enterococcus faecalis,
direkt aus klinischen Proben.
Zeitsparend
• Präsumtive Identifizierung von Vancomycinresistenten
E. faecium und E. faecalis nach 24 Stunden, direkt aus
der Probe
Bequem und Einfach Anzuwenden Die Unterscheidung zwischen Vancomycinresistenten
• Schnelles und einfaches Screeningtestverfahren E. faecium und E. faecalis wird erzielt durch zwei
chromogene Substanzen, welche durch spezifische
• Klare Unterscheidung zwischen E. faecium und Enzyme gespalten werden: Phosphatase und
E. faecalis α-Galactosidase. Die Spaltung der Chromogene
• Direkte Beimpfung aus Stuhlproben, Probentupfern, durch diese Enzyme resultiert in einer Farbgebung
Isolaten oder Suspensionen der Kolonie. Die Entstehung der Farbgebung ist
abhängig von dem Enzym, welches der Organismus
Selektiv besitzt. Sowohl E. faecium als auch E. faecalis
• Die Inhibierung der natürlich resistenten E. casseliflavus exprimieren die Phosphatase, welche eine
und E. gallinarum reduziert falsch-positive Ergebnisse im Blaufärbung der Kolonien hervorruft. Da E. faecalis
Vergleich zu traditionellen Medien und minimiert dadurch zudem noch die α-Galactosidase besitzt, entsteht
den Einsatz von Bestätigungstesten durch eine Mischung der beiden Chromogenen
die violette Färbung der Kolonien, was eine
Kostensparend Unterscheidung zu den blauen Kolonien von
• Infektionskontrollmaßnahmen und eine adäquate E. faecalis erleichtert.
Behandlungstherapie können durch die frühzeitige
präsumtive Identifizierung von E. faecium und E. faecalis Die Zugabe von weiteren antibakteriellen
zeitnah eingeleitet werden. Komponenten, in Kombination mit Vancomycin,
unterdrücken das Wachstum der Begleitflora wie
E. casseliflavus und E.gallinarum, welche eine
natürliche Resistenz, die chromosomal vermittelte
VanC Resistenz, gegen Vancomycin besitzen.
References:
1. Bell J.M., Paton J.C., Turnidge J. (1998). Emergence of Vancomycin Resistant Die VanC Resistenz ist nicht übertragbar auf
Enterococci in Australia: Phenotypic and Genotypic Characteristic of Isolates. J. Clin.
Microbiol. 36, 2187-2190. andere Organismen und ist klinisch signifikant
2. Centers for Disease Control and Prevention (2006). Recommendations for Preventing unbedeutender, als die VanA und VanB Resistenz.
the Spread of Vancomycin Resistance: HICPAC. Die VanA und VanB Resistenz wird über genetische
3. Delmas J., Robin F., Schweitzer C., Lesens O., Bonnet R. (2007). Evaluation of a new
Elemente wie Plasmide und Transposons übertragen
chromogenic medium, chromID VRE, for detection of Vancomycin Resistant Enterococci
in stool samples and rectal swabs. J. Clin. Microbiol. 45, 2731-2733. und erhöhen somit das Risiko der Übertragung der
4. Data on file at Oxoid, based on growth or inhibition. Resistenzgene auf andere Organismen.
2
Performance Oxoid Brilliance Agar Ready-Poured Plates
LeistungscharakterstikaPerformance Oxoid Brilliance Agar Ready-Poured Plates
Vancomycin Resistant Enterococci (VRE) have recently emerged as Order Information
Vancomycinresistente-Enterokokken (VRE) haben sich Thermo Scientific Brilliance VRE Agar wurde in einer
nosocomial pathogens, due to the Vancomycin increased use Resistant
of vancomycin Enterococci for (VRE) have recently emerged as Order Information
zutreatment
nosokomialen Pathogenen entwickelt,
nosocomial pathogens,
of meticillin-resistant Staphylococcus aureus in the United States aufgrund due to des
the increased use Description
klinischen
of vancomycin Studie
for mit 120 gut Packaging
charakterisierten, Ref
klinischen
treatment of meticillin-resistant Staphylococcus aureus in the United States Description Packaging
häufigen Einsatzes von Vancomycin zur Behandlung von
of America and use of a vancomycin-like glycopeptide (avoparcin) as a Isolaten getestet. Brilliance VRE Agar erzielte eine PO1175A
Brilliance VRE Agar 10x90mm plates
Performance
growth promoter in animal Staphylococcus of America and
1 use of a vancomycin-like glycopeptide
husbandry in Europe . aureus in den USA Oxoid Brilliance
(avoparcin) as Agar
a Ready-Poured
Brilliance VRE Plates
Agar 10x90mm pla
MethicillinresistentenPerformance growth promoter in animal husbandry in Europe 1Sensitivität
Other
. ProductsOxoidvon 94,7%
in Brilliance
the und
Brilliance Agar 100%
Resistance nach
Ready-Poured
Screening24 Plates
undRange48 Stunden.
Vancomycin Resistant
CentersEnterococciDisease(VRE) have andrecently emerged as that OtherInformation
Products
In the
und demU.S.A., the
Vancomycin
Vancomycin
forähnlichen
Resistant
Control
Enterococci
Wachstumsfaktor Prevention
(VRE) have
reported
recently
inemerged
der as Aus derMRSA
Brilliance Studie
2 Agar geht
Order
(UK)that auch hervor, 10x90mm dass inbereitsthe Brilliance Resistance
plates nach 24
PO1210A
Screenin
nosocomial pathogens,
as many as 1 in 3 infections due to the
In increased
the U.S.A., usethe of vancomycin
Centers for for
Disease Control and Prevention reported Order Information
1 amongst intensive care patients were caused Description Packaging Ref
Tierhaltung
by treatment
VRE 2. Earlyof
indetection
Europa
nosocomial .VRE is important
pathogens,
meticillin-resistant
of due to as
Staphylococcus
as many the
for1increased
in aureus
3 infections
infection use
in the
control ofamongst
vancomycin
United
and States
Stunden
for care
intensive patients
Brilliance MRSA mit
were Brilliance
2 Agar caused VRE Agar mehr
(rest of Europe)
Brilliance MRSA
10x90mm
2 Positve
Agar
plates detektiert
(UK)
PO5310A
10x90mm pla
treatment ofof ameticillin-resistant Staphylococcus Description Packaging Ref
of America
prevention and use epidemiological
measures, vancomycin-like
by VRE 2 glycopeptide
. Early
infectious detection
disease ofaureus
(avoparcin)
follow-up,VRE isand in
as the
aalsoUnited
important forStates
wurden als
Brilliancecontrol
infection auf
VRE Agar andMitbewerbermedien Brilliance MRSA . 2 Agar (rest
410x90mm plates
of Europe) PO1175A 10x90mm pla
Brilliance ESBL Agar 10x90mm plates PO5302A
growth of
promoter America
in and
animal use of
husbandrya vancomycin-like
prevention in Europe
measures, 1
. glycopeptide
epidemiological (avoparcin)
3 infectious as a disease Brillianceand
follow-up, VREalso
Agar 10x90mm plates PO1175A
Inprevention
den USA of vancomycin
berichtet resistant das CDC Staphylococcus
(Center for aureus
Disease emergence . Other Products in Brilliance ESBL Agar
3the Brilliance Resistance Screening Range
10x90mm pla
growth promoter in animal prevention husbandry of in
vancomycinEurope 1
.
resistant Staphylococcus aureus emergence .
In the
Control U.S.A.,
and the Centers
Agar wasforevaluated
Prevention), Disease
dass eineControl
at a von and
drei Prevention
Infektionen reported that Thermo Scientific Brilliance VRE Agar ist for
nurall für
yourden
Oxoid Brilliance VRE clinical trial site, using a panel Other Products in the Brilliance Resistance Screening Range
as many asIn1the in 3U.S.A., the Centers
infections OxoidforBrilliance
amongst Diseasecare
intensive Control
VRE and
patients
Agar wasPrevention
were caused
evaluated reported The
at a clinicalthat Oxoid
Brilliance product
MRSA
trial site, usingrange
2 Agar
a panel offers the complete
(UK) solution
10x90mm plates VREPO1210A
of 120
auf by der well-characterised,
Intensivstation stored clinical isolates. Brilliance VRE Agar gave The Oxoid product range offers the complete solution for
ofdurch VRE verursacht werden. Laborgebrauch bestimmt und nur von erfahrenem
2
screening
Brillianceand Brilliance
testing MRSA
(rest 2ofAgar
needs. (UK) 10x90mm plates PO5310A PO1210A
VRE ofas94.7%
. Early many as
detection 1 100%
in 3VRE
infections
is24importantamongst intensive
for infection care
control patients
and were caused MRSA 2 Agar Europe) 10x90mm plates
2
a sensitivity and of
at 120 and well-characterised,
48 hours respectively, stored clinical
with the isolates. Brilliance VRE Agar gave screening and testing needs.
Die frühzeitige
trialprevention by
Performance
site reporting VRE Erkennung
that. Early
measures, 2
ablevon
detection
epidemiological
it was to ofVRE
detectVRE isist
infectious
a sensitivity more wichtig
ofimportant
disease
94.7%
positives for
and für infection
atfollow-up,
100%
24 hours control
at and
24
than alsoand
and Personal
48 hours einzusetzen.
Brilliance
respectively,
Oxoid
Brilliance withMRSA
Brilliance
ESBL Agar theAgar Das
2 Agar Medium
(rest
Ready-Poured darf
of Europe) 10x90mm
Platesnach
plates Ablauf
10x90mm plates
PO5302A PO5310A
prevention prevention
of vancomycin measures,
resistantepidemiological
trial Staphylococcus
site reporting infectious
aureus
that disease
emergence follow-up,
3
. and Culti-Loops
also
™
Infektionskontrollen
with the competitor chromogenic und zuragar Prävention
currently von
in use . it was able to detect moredes
4 Vancomycin positives at Brilliance
24 hoursESBL
Mindesthaltbarkeitsdatums thanAgar
Culti-Loopsoder ™ bei sichtbaren
10x90mm plates PO5302A
VancomycinpreventionResistant Enterococci
of vancomycin the(VRE)
with resistant competitorhave recently
Staphylococcus
chromogenic emerged
aureus
agar asemergence in3. use4.Control Strain
currently Positive Order Information
resistenten
Oxoid
In a separate
nosocomial Staphylococcus
Brilliance
internalVRE Agar
evaluation,
pathogens, was toaureus
evaluated
dueusing panel. of 79use
at
thea increased
3
a clinical trial
nonofVRE site, using
strains, for
vancomycin a panel Verfallszeichen
The Oxoid productnicht range mehroffers theeingesetzt
complete
Positive
werden. Die
Control solution
Strain for all your VRE
of 120
Brilliance VRE
treatment Oxoid of Brilliance
well-characterised,
Agar was 100% VRE
storedAgar
selective
meticillin-resistant was
In clinical evaluated
isolates.
a Staphylococcus
separate
compared aataureus
a clinical
toBrilliance
internal evaluation,
competitor inVRE trial
the Agar
using
media,site,
United a using
gavepanel aof
States panel
79 Description
non
Enterococcus
Identifizierungen
screening VRE strains,
faecalis
The
and (Vancomycin
Oxoid
testingsind
product
needs. Resistant)
präsumtiv
range offersund Packaging
sollten
the complete bestätigt for all Ref
solution CL1996 your VRE
a sensitivity of 120
of well-characterised,
94.7% and 100% at 24
Brilliance stored
and VRE clinical
48 hours
Agar isolates.
was respectively,
100% Brilliance
with
selective VRE
the Agar
compared gave
ATCC to®
a competitor
51299 ™†
media, Enterococcus faecalis (Vancomycin Resistant)
which achieved selectivity of 94%.
of America and use a vancomycin-like glycopeptide (avoparcin) as a werden. Brilliancescreening
VRE Agar and testing needs. 10x90mm plates PO1175A
a sensitivity
trial site reporting that of 94.7%
it was ableand
which 100%
to detect
achieved at
more 24selectivity
and1 48 hours
positives 24respectively,
ofat94%. hours than with the ATCC 51299
® ™†
Oxoid growth promoter in isanimal in husbandry in Europeonly, . by trained Negative Control Strains
Culti-Loops ™
withBrilliance trialVRE
the competitor siteAgar reporting for that
chromogenic vitro diagnostic
itagar
was able to use
currently detect
in use4more . positives at 24 hours than Other Products in™the Brilliance NegativeResistance Screening Range
Control Strains
microbiologists. Oxoid Brilliance VRE Agar is for in vitro diagnostic use only, by trained
Culti-Loops
withIt the
In the U.S.A., must the not be used
Centers
competitor for beyond its
Disease
chromogenic stated
Control
agar and expiry
currently date,
in useor4.reported
Prevention if the that Enterococcus faecium
Positive Control ATCC® 35667™†
Strain CL1956
In a as
product separate
shows
many any internal
as in 3evaluation,
1signs using Identifications
of deterioration.
infections amongst a panel
microbiologists.
intensiveofIt 79
must
carenon
arenot VRE be strains,
used
presumptive
patients were beyond
caused
Brilliance
its stated expiry MRSA
date, 2if Agar
orControl
the (UK) Enterococcus faecium 10x90mm
ATCC® plates
35667™† PO1210A
Enterococcus
Enterococcus Positive
faecalis ATCC
faecalis
® Strain™†
19433 Resistant)
(Vancomycin CL1990
andBrilliance
should In
VRE
be a separate
Agar
2 confirmed. was internal
100% evaluation,
selective
product showsusing
compared
by VRE . Early detection of VRE is important for infection control and any a panel
to
signsa of
of 79
competitor non VRE
media,
deterioration. strains,
Identifications are presumptive
Brilliance MRSA 2 Agar (rest of Europe)
Enterococcus 10x90mm ® plates ™† CL1996
faecalis ATCC 19433 PO5310A
which Brilliance
achieved VRE Agar
selectivity was
of 94%. and100%shouldselective
be confirmed.compared to a competitor media,ATCC® 51299
Enterococcus
™†
Enterococcus
gallinarum ATCCfaecalis
® (Vancomycin
700425 ™† Resistant) R4601958 CL1996
prevention measures, epidemiological infectious disease follow-up, and also Brilliance ESBL
ATCC ® Agar ™†
51299 Enterococcus 10x90mm
gallinarum ATCCplates
®
700425™† PO5302A
preventionwhich achieved selectivity of 94%. Negative Control Strains
Oxoid BrillianceofVRE vancomycin
Agar is forresistant Staphylococcus
in vitro diagnostic use only, aureus emergence .
by trained 3
Screening Oxoid
Procedure
Brilliance VRE Agar is for in vitro diagnostic ConfirmatoryNegative Tests ATCC®Strains
faeciumControl
microbiologists. It must not
Oxoid Brilliance VRE Agar was evaluated be used beyond
Screening its stated Procedure
at a clinical trial site,only,
expiry use
date, or ifbythe
using atrained
panel Enterococcus
The Oxoid™ product
35667™† Confirmatory
™ range offers® the complete
Tests CL1956
solution for all R8311003
your VRE CL1956
product microbiologists.
shows any signs of It must not
deterioration. be used beyond
Identifications its stated
are expiry
presumptive date, or Thermo
if the Scientific RapID
Enterococcus STR
faecium ATCC 3566720™† test panels
of 120 well-characterised, stored clinical isolates. Brilliance VRE Agar gave Enterococcus faecalis ATCC ®
19433 ™†
CL1990 20 test panels
Screening Prozess
and aInoculate
should product
directly with
and
be confirmed.
Brilliance
sensitivity peashould
of shows
VRE
sized bead
plate any
94.7% and signs
100%
beorconfirmed. to
ofatdeterioration.
24 and 48
Inoculate Brilliance
Identifications
hours
Indigo
VRE toplate
respectively,
Purple
are with
presumptive
the
screening and
Rapid identification
Enterococcus
testing needs.
of streptococci
faecalis
Enterococcus gallinarum ATCC 700425
Thermo Scientific™ RapID™ STR
and enterococci
® ATCC ™†
®
19433 ™†
R4601958 CL1990
Rapid identification of streptococci and enterococci
trialloopful
site ofreporting
specimen. that it was able directly detect more
with pea E.positives
sized faecium
bead or at 24 hours than Streptococcus Grouping Kit
Indigo to Purple
Enterococcus
50 tests
ATCC 700425Grouping Kit
gallinarum Streptococcus
® ™†
DR0585A
R4601958
Culti-Loops
E.PYR
faecium
™
50 tests
with the competitor
Screening chromogenic agarloopful
Procedure
of specimen.
currently in use4. O.B.I.S.
Confirmatory Tests 60 tests ID0580M
Positive Control Strain O.B.I.S. PYR 60 tests
In aDirekte
separate Screening
Beimpfung Procedure
der
internal evaluation, using a panel of 79 non VRE strains, Confirmatory
Thermo Scientific ™
RapID™ STR Tests 20 test panels R8311003
Brilliance
Brilliance VRE Agar VRE-Platte
was 100% selective compared to a competitor media, Antimicrobial Susceptibility
Enterococcus faecalis (Vancomycin Testing M.I.C.Evaluator
™ Resistant) Strips
Inoculate Brilliance VRE plate Thermo™†
Rapid identification ofScientific ™
RapID
streptococci and STR
enterococci
Antimicrobial 20 test panels
Susceptibility Testing CL1996 R8311003 S
M.I.C.Evaluator
mit
which einer erbsengroßen ATCC® 51299
directlyachieved
with peaInoculateselectivity
sized bead or of 94%.
Brilliance VRE plate
Indigo
Light Blueto Purple M.I.C.Evaluator ™
Strips
Rapid identification of streptococci and enterococci
Menge oder einer Impföse. Streptococcus Grouping Kit M.I.C.Evaluator 50
™ tests DR0585A
loopful of specimen.
directly with pea sized bead or
Oxoid Brilliance VRE Agar is for in vitro diagnostic use only,
E. faecium
E. faecalis
Indigo to Purple
byE.trained For the Negative
Light Blue Control
accurate Strainsof the minimum
determination inhibitory Strips
concentration (MIC) of a test
loopful of specimen. Dunkelblau
faecium bis Hellbau
E. faecalis
O.B.I.S.toPYR Streptococcus Grouping Kit 50
60determination
tests tests ID0580M DR0585A
organism an antimicrobial For the accurate of the minimum inhibitory concent
microbiologists. It must not be used beyond its stated expiry Violettdate, or if the
E. faecium E.Enterococcus
faecalis faecium ATCC® 35667™†
O.B.I.S. PYR organism to an antimicrobial 60 tests
CL1956
ID0580M
product shows any signs of deterioration. Identifications are presumptive Vancomycin 256 - 0.016μg/mL ® 10 strips MA0102D
EnterococcusSusceptibility
Antimicrobial faecalis ATCC 19433 ™†
Testing
VancomycinM.I.C.Evaluator
256 - 0.016μg/mL Strips CL199010 strips
ORbe confirmed.
and should POSITIVE Vancomycin 256 - 0.016μg/mL Susceptibility 50 strips MA0102F
OR POSITIVE
Enterococcus
M.I.C.Evaluator Antimicrobial
™ gallinarum ATCC® 700425™†Testing M.I.C.Evaluator Strips
Strips Vancomycin 256 - 0.016μg/mL R460195850 strips
Light Blue
E. faecalis Light Blue POSITIV M.I.C.Evaluator ™
Strips
For the accurate determination of the minimum inhibitory concentration (MIC) of a test
Discs
Screening
Pre-enrich in suitable Procedure
Incubate plates at
37°C for 24hr
E. faecalis Confirmatory
organism to For Tests determination
an antimicrobial
the accurate Discsof the minimum inhibitory concentration (MIC) of a test
Incubate plates at
selective broth prior to Pre-enrich in suitable Antimicrobial susceptibility
organism to testing
an discs for use with appropriate AST media in accordance
antimicrobial
37°C for 24hr Vancomycin 256 - 0.016μg/mL
Thermo Scientific RapID STR Antimicrobial susceptibility
™ ™ 10 strips
20 test panels MA0102D
R8311003
inoculation onto a Brilliance selective broth prior to with CLSI M44-A. testing discs for use with appropriate A
Use OR
VRE plate.Inoculate oder
an incubation
Brilliance VRE plate inoculation onto a POSITIVE
Brilliance Rapid Vancomycin
identification
Vancomycin 256 - 0.016μg/mL 256
of - 0.016μg/mL
streptococci and enterococci
with CLSI M44-A. 50 strips 10 strips MA0102F MA0102D
protocoldirectly
appropriate to the
with pea sizedORbead or VRE plate. Use an incubation
NEGATIVE Indigo toPOSITIVE
Purple Inkubation Vancomycin 5μg Discs 5x50 discs CT0188B
broth chosen. protocol appropriate to the E. faecium beiStreptococcus
Vancomycin 256 Kit
Grouping - 0.016μg/mL 50 tests50 strips DR0585A MA0102F
loopful of specimen. NEGATIVE Vancomycin 5μg Discs 5x50 discs
broth chosen. 37 ºC für 18-24 Stunden
Vancomycin
Discs 30μg Discs 5x50 discs CT0058B
Incubate plates at O.B.I.S. PYR Vancomycin 30μg Discs 60 tests ID0580M 5x50 discs
Pre-enrich in suitable 37°C for 24hrIncubate plates at Discs
selective broth Pre-enrich
prior to in suitable Antimicrobial susceptibility testing discs for use with appropriate AST media in accordance
inoculation onto aselective
Brilliancebroth prior to 37°C for 24hr
with Antimicrobial
CLSI M44-A.AntimicrobialSusceptibility Testing
susceptibility testing M.I.C.Evaluator
discs StripsAST media in accordance
for use with appropriate
VRE plate. Use an incubation
inoculation onto a Brilliance Negative plates should be For morewith information about the Thermo Scientific Brilliance
protocol appropriate to the Vancomycin 5μg CLSI™ M44-A.
Discs 5x50 discs CT0188B
VRE plate. Use an incubation NEGATIVE
re-incubated for an additional
Light Blue NegativeM.I.C.Evaluator
NEGATIVrange of chromogenic media andFor
plates should be Strips more information about the Thermo Scientific
broth chosen.
protocol appropriate to the 24 hoursE. faecalis re-incubated for anVancomycin
additional determination
5μg Discs other products, please
5x50 discs a testCT0188B
NEGATIVE For
Vancomycin the accurate
30μg Discs of the minimum
range of inhibitory
chromogenic
5x50 discs concentration
media (MIC)
and ofother
CT0058B products,
broth chosen. 24 www.thermoscientific.com/microbiology
hours
visitorganism to an antimicrobial or talk
to your
Vancomycin 30μg Discs
local representative. visit www.thermoscientific.com/microbiolog
5x50 discs CT0058B
Vancomycin 256 - 0.016μg/mL 10 strips MA0102D
Please note, organisms with an atypical enzyme pattern may give anomalous reactions on to your local representative.
Brilliance VRE Agar. OR Please note, organismsNegative POSITIVE
with anplates should
atypical beBei
enzyme einem
pattern may givenegativen For
anomalous more
reactionsinformation
Vancomycin 256
on - 0.016μg/mL about the Thermo Scientific
50 strips Brilliance MA0102F
Voranreicherung in einer Brilliance VRE Agar. re-incubated for Negative
an additional
geeigneten selektiven
The ATCC Licensed Derivative Emblem, the ATCC 24 Licensed
hours Ergebnis,
plates should
Derivative
Platten
be für weitere
mark, and therange
For more
of chromogenic information
media about
and Thermo the Thermo
other Fisher
products, Scientific
Scientificplease
Brilliance
†
for an word ATCC catalog marks are trademarks of ATCC. is licensed
®
re-incubated additional
Bouillon vor der Beimpfung
to use †
these trademarks and Incubate plates
to sell The ATCC
at derived from ATCC®
®
products
24
Licensed Stunden
Derivative
24 hours inkubieren.
Emblem, the Discs range of
Derivativechromogenic
ATCC www.thermoscientific.com/microbiology
cultures. Look for thevisit
ATCC Licensed word mark, and themedia
ATCC and
catalog other
marks areproducts,
Licensed Derivative® Emblem for products derived from ATCC® cultures. trademarks please
or talk ATCC. Thermo Fisher Scie
of
Pre-enrich in suitable 37°C for 24hr
auf Brilliance VREprior
selective broth Agar.to Die
to use these trademarks and to sell products
to derived visit
from www.thermoscientific.com/microbiology
ATCC®
your localsusceptibility
Antimicrobial cultures.
representative. Look for the ATCC Licensed Derivative®
testing discs for use with appropriate AST oraccordance
Emblem for products
media in talkderived from ATC
thermoscientific.com/microbiology
PleaseBouillon inoculation
note, organisms ontoan
entsprechend
with a Brilliance der
atypical enzyme pattern may give anomalous reactions on
plate. Use an incubation thermoscientific.com/microbiology
with CLSI to your
M44-A. local representative.
Brilliance VREVREAgar.
Empfehlung
Please note, inkubieren.
organisms with an atypicalAll
enzyme patternare
may give anomalous
© 2013 Thermo Fisher Scientific
protocol Inc. All
appropriate rights
to the reserved. trademarks property of Thermoreactions on
Fisher Scientific Inc., and its subsidiaries.
Vancomycin 5μg Discs 5x50 discs CT0188B
Brilliance VRE Agar.
broth
NEGATIVE
® chosen. © 2013 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are property of Thermo Fisher Scientific Inc., and its subsidiaries.
† The ATCC Licensed Derivative Emblem, the ATCC Licensed Derivative word mark, and the ATCC catalog marks are trademarks of ATCC. Thermo Fisher Scientific is licensed
Vancomycin 30μg Discs 5x50 discs CT0058B
Contact Information: † to use these
® trademarks and to sell
The ATCC Licensed productsEmblem,
Derivative derived from ATCC®
the ATCC cultures.
Licensed Look forword
Derivative the ATCC
mark,Licensed Derivative®
and the ATCC catalog Emblem fortrademarks
marks are products derived from
of ATCC. ATCC®
Thermo cultures.
Fisher Scientific is licensed
International Contact Information:
to use these trademarks and to sell products derived from ATCC® cultures. Look for the ATCC Licensed Derivative® Emblem for products derived from ATCC® cultures.
+44
Bitte thermoscientific.com/microbiology
(0) 1256
beachten dass Organismen mit einem International
Sie, 841144 atypischen Enzymmuster auf Brilliance VRE Agar anomale Reaktionen hervorrufen können.
thermoscientific.com/microbiology
oxoid.info@thermofisher.com +44 (0) 1256 841144 Negative plates should be For more information about the Thermo Scientific Brilliance
© 2013 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are property
re-incubated of additional
for an Thermo Fisher Scientific Inc., and its subsidiaries.
oxoid.info@thermofisher.com
24 hours range ofand
chromogenic
its subsidiaries. media and other products, please
© 2013 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are property of Thermo Fisher Scientific Inc., 3
1282/MS/01/11
Contact Information: visit www.thermoscientific.com/microbiology or talk
1282/MS/01/11
InternationalContact Information: to your local representative.
+44 (0) 1256 841144
InternationalBrilliance Fertignährmedien
Bestellinformationen
Produktname Packungsgröße Art.-Nr.
Brilliance VRE Agar 10x90 mm Platten PO1175A
Weitere Produkte der Brilliance Screeningmedien Produktpalette
Brilliance MRSA 2 Agar (UK) 10x90 mm Platten PO1210A
Brilliance MRSA 2 Agar (Europa) 10x90 mm Platten PO5310A
Brilliance ESBL Agar 10x90 mm Platten PO5302A
Brilliance CRE Agar 10x90 mm Platten PO1226A
Das Thermo Scientific Produktangebot bietet die komplette VRE Screening und Testungslösung:
Culti-Loops™
Postive-Qualitätskontrollstämme:
Enterococcus faecalis (Vancomycin Resistant) ATCC® 51299™† R4601996
Negative-Qualitätskontrollstämme:
Enterococcus faecium ATCC® 35667™† R4601956
Enterococcus faecalis ATCC 19433 ® ™†
R4601990
Enterococcus gallinarum ATCC 700425 ® ™†
R4601958
Enterococcus casseliflavus ATCC 25788 ® ™†
R4609289
Enterococcus faecalis ATCC® 29212™† R4607030
Escherichia coli ATCC 25922 ® ™†
R4607050
Bestätigungstests
Thermo Scientific™ RapID™ STR 20 Tests R8311003
Zur schnellen Identifizierung von Entero- und Streptokokken
Streptococcus Grouping Kit 50 Tests DR0585A
O.B.I.S. PYR 60 Tests ID0580M
Antibiotika-Testblättchen
Testblättchen zur antimikrobiellen Empfindlichkeitsprüfung mit geeignetem Nährmedien nach CLSI M44-A.
Vancomycin 5 μg Discs 5x50 Testblättchen CT0188B
Vancomycin 30 μg Discs 5x50 Testblättchen CT0058B
†
The ATCC Licensed Derivative Emblem, the ATCC Licensed Derivative word mark and the ATCC catalog marks are trademarks of ATCC.
Remel Inc. is licensed to use these trademarks and to sell products derived from ATCC® cultures. The identity, purity, and authenticity of
the Licensed Products are exclusively the responsibility of Remel Inc., and not ATCC.
Contact Information:
DACH
+ 49 281 152 0
microbiology.techsupport.de@thermofisher.com
Weitere Informationen über diese Produkte und andere chromogene Nährmedien aus
der Thermo Scientific Brilliance Produktreihe sind im Internet unter
thermoscientific.com/microbiology erhältlich oder bei
Ihrem lokalen Ansprechpartner.
© 2021 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientific and its subsidiaries
unless otherwise specified. LT2651A May 2021You can also read
